The National Institute for Health and Care Excellence recommends glucose monitoring devices for all patients with Type 1 diabetes: anticipating further increase in cutaneous reactions to these devices
Authors:
Open Access
- 16 November 2022
- journal article
- letter
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 48 (4) , 382-383
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Contact allergy to the Dexcom G6 glucose monitoring system—Role of 2,2′‐methylenebis(6‐tert‐butyl‐4‐methylphenol) monoacrylate in the new adhesiveContact Dermatitis, 2022
- Freestyle libre 2: The new isobornyl acrylate free generationContact Dermatitis, 2020
- Measures of Accuracy for Continuous Glucose Monitoring and Blood Glucose Monitoring DevicesJournal of Diabetes Science and Technology, 2018
- Allergic contact dermatitis caused by isobornyl acrylate in Freestyle® Libre, a newly introduced glucose sensorContact Dermatitis, 2017